Laparoscopic transperitoneal radical nephrectomy for renal masses with level I and II thrombus

dc.contributor.authorÇınar, Önder
dc.contributor.buuauthorGünseren, Kadir Ömür
dc.contributor.buuauthorÇiçek, Çağatay
dc.contributor.buuauthorVuruşkan, Berna Aytaç
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Üroloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0001-8673-3093tr_TR
dc.contributor.researcheridABC-9924-2020tr_TR
dc.contributor.researcheridAAH-9746-2021tr_TR
dc.contributor.scopusid56664496600tr_TR
dc.contributor.scopusid57205388104tr_TR
dc.contributor.scopusid56527372000tr_TR
dc.date.accessioned2024-01-09T06:47:19Z
dc.date.available2024-01-09T06:47:19Z
dc.date.issued2018-01
dc.description.abstractBackground: We aimed to report surgical and oncological outcomes of renal cell carcinoma (RCC) patients with level I and II thrombus treated with laparoscopic transperitoneal radical nephrectomy. Patients and Methods: Medical records of 13 patients were reviewed retrospectively in a single center between 2005 and 2017. Hem-o-lok((R)) clips were used to secure renal artery and renal vein, excluding 2 patients with an attached thrombus on the right side. Results: Seven male and 6 female patients were treated laparoscopically, and conversion to open surgery was not required in any case. The mean age was 61.67.8 years (range 45 to 75 years) and the mean body mass index was 27 +/- 4.6kg/m(2) (range 18.8 to 34.5kg/m(2)). Median tumor size was 9.5x7.3cm (range 5 to 14cm) and 5 patients who had preoperative metastases underwent cytoreductive nephrectomy. The mean operative time was 137.6 +/- 45.8 minutes (range 60 to 200 minutes) and blood loss was 105 +/- 34.9mL (range 50 to 150mL). The mean hospital stay was 4.4 +/- 3.9 days (range 1 to 15 days). Splenic capsular injury occurred in 1 patient and the vena cava was injured in another. Three patients needed blood transfusions. The mean follow-up period was 25 months (range 12 to 86 months). Conclusion: Laparoscopic transperitoneal radical nephrectomy can be reliable option for surgical management of RCC with level I and II thrombus in experienced centers.en_US
dc.identifier.citationÇınar, Ö. vd. (2018). ''Laparoscopic transperitoneal radical nephrectomy for renal masses with level I and II thrombus''. Journal of Laparoendoscopic and Advanced Surgical Techniques, 29(1), 35-39.en_US
dc.identifier.endpage39tr_TR
dc.identifier.issn1092-6429
dc.identifier.issn1557-9034
dc.identifier.issue1tr_TR
dc.identifier.pubmed30004287tr_TR
dc.identifier.scopus2-s2.0-85059850465tr_TR
dc.identifier.startpage35tr_TR
dc.identifier.urihttps://doi.org/10.1089/lap.2018.0320
dc.identifier.urihttps://www.liebertpub.com/doi/10.1089/lap.2018.0320
dc.identifier.urihttps://hdl.handle.net/11452/38868
dc.identifier.volume29tr_TR
dc.identifier.wos000438829100001tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherMary Ann Liebert Inc.en_US
dc.relation.collaborationYurt içitr_TR
dc.relation.journalJournal of Laparoendoscopic and Advanced Surgical Techniquesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSurgeryen_US
dc.subjectLaparoscopyen_US
dc.subjectRenal canceren_US
dc.subjectNephrectomyen_US
dc.subjectThrombusen_US
dc.subjectCell carcinomaen_US
dc.subjectSurgical-treatmenten_US
dc.subjectVein thrombusen_US
dc.subjectManagementen_US
dc.subjectCanceren_US
dc.subjectOutcomesen_US
dc.subject.emtreeInterferonen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAgeden_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBlood transfusionen_US
dc.subject.emtreeBody massen_US
dc.subject.emtreeBone metastasisen_US
dc.subject.emtreeCancer radiotherapyen_US
dc.subject.emtreeCancer stagingen_US
dc.subject.emtreeCancer surgeryen_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeComputer assisted tomographyen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeConversion to open surgeryen_US
dc.subject.emtreeCytoreductive surgeryen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeFollow upen_US
dc.subject.emtreeHospitalizationen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeKidney arteryen_US
dc.subject.emtreeKidney veinen_US
dc.subject.emtreeLaparoscopic surgeryen_US
dc.subject.emtreeLaparoscopic transperitoneal radical nephrectomyen_US
dc.subject.emtreeLiver metastasisen_US
dc.subject.emtreeLung metastasisen_US
dc.subject.emtreeLymph node dissectionen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeNuclear magnetic resonance imagingen_US
dc.subject.emtreeoperation durationen_US
dc.subject.emtreePostoperative hemorrhageen_US
dc.subject.emtreePreoperative perioden_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeRadical nephrectomyen_US
dc.subject.emtreeRenal cell carcinomaen_US
dc.subject.emtreeRetrospective studyen_US
dc.subject.emtreeSpleen injuryen_US
dc.subject.emtreeTumor thrombusen_US
dc.subject.emtreeTumor volumeen_US
dc.subject.emtreeComplicationen_US
dc.subject.emtreeInferior cava veinen_US
dc.subject.emtreeKidney tumoren_US
dc.subject.emtreeLparoscopyen_US
dc.subject.emtreeLength of stayen_US
dc.subject.emtreeMiddle ageden_US
dc.subject.emtreeNephrectomyen_US
dc.subject.emtreePathologyen_US
dc.subject.emtreePeritoneumen_US
dc.subject.emtreeProceduresen_US
dc.subject.emtreeRenal cell carcinomaen_US
dc.subject.emtreeStatistics and numerical dataen_US
dc.subject.emtreeSurgical equipmenten_US
dc.subject.emtreeTreatment outcomeen_US
dc.subject.emtreeVein thrombosisen_US
dc.subject.meshAgeden_US
dc.subject.meshCarcinoma, renal cellen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshKidney neoplasmsen_US
dc.subject.meshLaparoscopyen_US
dc.subject.meshLength of stayen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshNephrectomyen_US
dc.subject.meshOperative timeen_US
dc.subject.meshPeritoneumen_US
dc.subject.meshRenal veinsen_US
dc.subject.meshRetrospective studiesen_US
dc.subject.meshSurgical instrumentsen_US
dc.subject.meshTreatment outcomeen_US
dc.subject.meshVena cava, inferioren_US
dc.subject.meshVenous thrombosisen_US
dc.subject.scopusKidney Tumor; Conversion to Open Surgery; Thrombus Aspirationen_US
dc.subject.wosSurgeryen_US
dc.titleLaparoscopic transperitoneal radical nephrectomy for renal masses with level I and II thrombusen_US
dc.typeArticleen_US
dc.wos.quartileQ3 (Surgery)en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections